tradingkey.logo
tradingkey.logo

Rhythm Pharma's obesity drug fails to meet main goal in late-stage trial

ReutersMar 16, 2026 8:05 PM

- Rhythm Pharmaceuticals RYTM.O said on Monday its experimental obesity drug in patients with rare genetic conditions did not meet the main goal of a late-stage trial.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI